Nonalcoholic fatty liver disease

J Atherosclerosis Prev Treat. 2022 Jan-Apr;13(1):17-25 | doi:10.53590/japt.02.1030 REVIEW ARTICLE Evangelia S. Makri, Stergios A. Polyzos First Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece     Abstract Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disease affecting millions of people worldwide with potentially serious complications that may lead to […]